Cannabidiol and Aza-BODIPY Coencapsulation for Photodynamic Therapy Enhancement in Liver Cancer Cells.
ACS Appl Bio Mater
; 7(6): 3890-3899, 2024 Jun 17.
Article
en En
| MEDLINE
| ID: mdl-38776245
ABSTRACT
Photodynamic therapy (PDT) and cannabidiol (CBD) have been explored for their potential in synergistic cancer treatment. In this study, we employed CBD oil as a lipid phase, encapsulated within AZB-I@Lec-T to create lipid-based nanoparticles. Here, CBD oil does two tasks it acts as a pyroptosis agent to destroy liver cancer cells and as a lipid phase to dissolve the photosensitizer. It was expected that this system would offer synergistic therapy between CBD and PDT better than a single use of each treatment. With a series of in vitro experiments, the nanoparticles exhibited induced apoptosis in 68% of HepG2 cells treated with AZB-I@Lec-T@CBD and near-infrared (NIR)-light irradiation, reducing expression levels of antioxidant defense system genes. Furthermore, both components worked well in a submicromolar range when combined in our formulation. These results highlight the potential for amplifying primary cellular damage with the combination of PDT and CBD encapsulation, providing a promising therapeutic approach for liver cancer treatment guidelines.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Tamaño de la Partícula
/
Fotoquimioterapia
/
Materiales Biocompatibles
/
Ensayo de Materiales
/
Compuestos de Boro
/
Cannabidiol
/
Ensayos de Selección de Medicamentos Antitumorales
/
Fármacos Fotosensibilizantes
/
Neoplasias Hepáticas
Idioma:
En
Revista:
ACS Appl Bio Mater
/
ACS appl. bio mater
/
ACS applied bio materials
Año:
2024
Tipo del documento:
Article